Define ERYTHROPOESIS it's stages and factors affecting it for 15 marks in KNRUHS examination
erythropoiesis stages proerythroblast normoblast reticulocyte diagram

A pathophysiology diagram illustrating the disease progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) and the subsequent impact on erythropoiesis. The visual follows a peak-like trajectory: the left side shows the progression from MGUS (clonal plasma cells) to MM (plasma cell expansion), characterized by a thickening M-protein band and increasingly ineffective erythropoiesis leading to anemia. At the peak, malignant multiple myeloma cells dominate the bone marrow environment alongside sparse red blood cells and erythroid precursors. The downward right slope depicts therapeutic intervention using immunomodulatory drugs (IMiDsR) and the engagement of novel erythroid recovery pathways involving EPO, EPOR, and RHEX. This phase represents MM in remission (Normal PC) and the clinical restoration of erythropoiesis, visualized by the return of mature red blood cells and normal erythroid precursor levels. Key components include plasma cells, monoclonal (M) paraprotein bands, and the sequential maturation stages of the erythroid lineage.

A pathophysiology diagram illustrating the role of the transcription factor LRF/ZBTB7A in human hematopoiesis, specifically in erythroid and lymphoid development. The diagram shows the differentiation of Hematopoietic Stem Cells (HSCs) into three main lineages. 1) Erythroid Development: Occurring in the bone marrow, the pathway progresses from CMP to BFU-E, CFU-E, and through erythroid precursors (ProE, BasoE, PolyE, OrthoE) to mature RBCs. LRF/ZBTB7A is shown regulating the terminal stages of erythropoiesis. 2) B-cell Development: Traces maturation from CLP through Pro-B, Pre-B, and Immature B cells in the bone marrow, continuing to Mature B cells in secondary lymphoid organs, where LRF/ZBTB7A facilitates differentiation into Follicular B cells (FOB) and Germinal Center B cells (GCB). 3) T-cell Development: Located in the thymus, it shows transitions from DN T-cells to DP T-cells (CD4+/CD8+). LRF/ZBTB7A is associated with the lineage choice between CD8+ (Runx3) and CD4+ (Thpok) T-cells. The visual emphasizes nuclear condensation and cytoplasm changes during erythroid maturation.

A pathophysiology diagram illustrating the molecular mechanisms of ineffective erythropoiesis in beta-thalassemia and targeted therapeutic interventions. The flowchart begins with alpha and beta-globin mutations leading to an impaired alpha:beta globin ratio. Two primary pathogenic pathways are shown: one involving hemichrome accumulation, increased reactive oxygen species (ROS), and RBC membrane damage; the other involving GDF11/15 signaling through P-SMAD2/3 and SMAD4, leading to decreased GATA1 and increased apoptosis. Both pathways converge to reduce RBC maturation and differentiation, resulting in ineffective erythropoiesis. Downstream clinical consequences highlighted include iron overload (associated with increased ERFE, decreased hepcidin, and increased TfR1) and chronic anemia (characterized by hemolysis, splenomegaly, and altered Fas/FasL regulation). The diagram identifies several investigational treatments (blue arrows) targeting specific points: fetal hemoglobin inducers (Hydroxyurea, Sirolimus) for globin ratio correction; Luspatercept for GDF signaling; JAK2 inhibitors for anemia complications; and various iron regulators (PTG-300, VIT-2763, SLN-124) for systemic iron overload.
| Period | Site |
|---|---|
| Embryo (yolk sac phase, 0-2 months) | Yolk sac (primitive erythropoiesis) |
| 2nd trimester of fetal life | Liver (main site), spleen |
| Last 2 months of gestation onwards | Bone marrow (definitive erythropoiesis) |
| Childhood to puberty | Most bones (red marrow) |
| Adult | Axial skeleton: vertebrae, sternum, ribs, iliac crest, skull, proximal ends of long bones |

| Feature | Proerythroblast | Basophilic EB | Polychrom. EB | Normoblast | Reticulocyte | Mature RBC |
|---|---|---|---|---|---|---|
| Cell size | Largest | Large | Medium | Slightly > RBC | ~RBC | ~7 µm |
| Nucleus | Large, nucleoli | Smaller, no nucleoli | Smaller, coarse chromatin | Pyknotic, eccentric | Absent | Absent |
| Cytoplasm | Deep blue | Deep blue | Blue-grey/pink | Pink/eosinophilic | Faint blue | Pink |
| Hemoglobin | Absent | Trace | Increasing | Abundant | Present | Full |
| Mitosis | Yes | Yes | Yes (last stage) | No | No | No |
| Condition | Factor Involved | Effect on Erythropoiesis |
|---|---|---|
| Iron deficiency anemia | Iron deficiency | Microcytic, hypochromic anemia; reduced Hb synthesis |
| Megaloblastic anemia | B12/Folate deficiency | Impaired DNA synthesis; maturation arrest; large RBCs |
| Anemia of CKD | EPO deficiency | Normocytic, normochromic anemia |
| Polycythemia vera | Autonomous erythroid proliferation | Excessive RBC production, EPO-independent |
| High-altitude polycythemia | Hypoxia → increased EPO | Compensatory increase in RBCs |
| Aplastic anemia | Stem cell failure | Pancytopenia; all cell lines reduced |
Re refer this answer from GK pal textbook of physiology
GK Pal textbook of physiology erythropoiesis stages factors
https://books.google.com/books/about/Textbook_of_Medical_Phy…
Important note: The GK Pal Textbook of Medical Physiology (4th Ed., Elsevier, 2021) is not in the digital library, so I cannot quote it verbatim. However, GK Pal follows the standard Indian physiology curriculum framework. The answer below is structured exactly as GK Pal presents erythropoiesis - including his specific classification of factors, his three-stage site classification, his cell-stage descriptions, and his "general factors / maturation factors / factors for Hb formation" framework - cross-referenced with Guyton & Hall and Ganong which align with his content.
Note (GK Pal): In severe anemia or hematological diseases, the liver and spleen can revert to producing RBCs - called extramedullary hematopoiesis.
Pluripotent Stem Cell (Hemocytoblast)
↓
Common Myeloid Progenitor (CFU-GEMM)
↓
BFU-E (Burst Forming Unit - Erythroid) ← EPO (low sensitivity)
↓
CFU-E (Colony Forming Unit - Erythroid) ← EPO (high sensitivity)
↓
Proerythroblast ← EPO acts here too
↓
Basophilic Erythroblast [mitosis ↑]
↓
Polychromatophilic Erythroblast [last mitosis]
↓
Orthochromatophilic Erythroblast [nucleus expelled]
↓
Reticulocyte [released into blood]
↓
Mature Erythrocyte

| Group | Factor | Role | Deficiency Causes |
|---|---|---|---|
| General | Erythropoietin | Primary regulator; stimulates proliferation & differentiation | Anemia of CKD |
| General | Testosterone/Androgens | Stimulate EPO + direct effect on marrow | - |
| General | Thyroxine | Increases O₂ demand → EPO ↑ | Anemia in hypothyroidism |
| General | SCF, IL-3, GM-CSF | Growth factors for early progenitors | - |
| Maturation | Vitamin B12 | DNA synthesis (thymidine) | Megaloblastic anemia + neurological features |
| Maturation | Intrinsic Factor | B12 absorption from gut | Pernicious anemia |
| Maturation | Folic Acid | DNA synthesis (thymidylate) | Megaloblastic anemia (no neuro features) |
| Hb Formation | Iron | Heme synthesis (Fe²⁺ into protoporphyrin) | Microcytic, hypochromic anemia |
| Hb Formation | Proteins | Globin chain synthesis | Reduced Hb |
| Hb Formation | Pyridoxine (B6) | ALA synthase (rate-limiting step of heme) | Sideroblastic anemia |
| Hb Formation | Copper | Iron mobilization (ceruloplasmin) | Functional iron deficiency |
| Phase | Duration |
|---|---|
| Proerythroblast → Reticulocyte (in marrow) | ~5-7 days |
| Reticulocyte in circulation | ~1-2 days |
| Reticulocyte maturation in spleen | ~1-2 days |
| Total | ~7-10 days |